FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol This marks the official ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback